REGENCIN

Welcome to the Brand page for “REGENCIN”, which is offered here for Medical and scientific research in the field of genetics, genetic engineering, biotechnology, and regenerative medicine; development of new technology and processes and biological, biomedical and biochemical preparations and solutions, cell preparations, enzymes, proteins, hormones, microbes, molecules and reagents for others in the fields of genetics, genetic engineering, biotechnology, and regenerative medicine;.

Its status is currently believed to be active. Its class is unavailable. “REGENCIN” is believed to be currently owned by “Pfizer Inc.”